What are new opportunities for clinical practice the VERIFY study opens and which values for native diabetes patients? Joint conclusion on the advisory board results. November 6, 2019

Marina V. Shestakova; Mikhail B. Antsiferov; Alexander S. Ametov; Gagik R. Galstyan; Tatiana Y. Demidova; Alexey V. Zilov; Tatiana N. Markova; Nina A. Petunina; Natalya A. Chernikova; Minara S. Shamkhalova

doi:10.14341/DM12404-9534

For citations:

Shestakova M.V., Antsiferov M.B., Ametov A.S., Galstyan G.R., Demidova T.Y., Zilov A.V., Markova T.N., Petunina N.A., Chernikova N.A., Shamkhalova M.S. What are new opportunities for clinical practice the VERIFY study opens and which values for native diabetes patients? Joint conclusion on the advisory board results. November 6, 2019. Diabetes mellitus. 2020;23(1):106-110. (In Russ.) https://doi.org/10.14341/DM12404

Views PDF (Rus): 108

JATS XML

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).

ISSN 2072-0351 (Print)
ISSN 2072-0378 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Diabetes mellitus

For citations:

Cookies policy